Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test

Overview of attention for article published in Multiple Sclerosis Journal, January 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

policy: 1 policy source
patent: 3 patents

f1000: 1 research highlight platform

Readers on

mendeley: 264 Mendeley

So far, Altmetric has seen 3 policy documents that reference this research output.

ozanimod - Clinical Report

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 23 Jun 2021

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

siponimod - Clinical Report

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 28 Aug 2019

Peginterferon beta-1a - Clinical Report

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 03 Jun 2015

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.